Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $373,774.85 mil
Piotroski score: 9
PE Ratio: 86.1257
EPS (TTM): 2.3828
Revenue (TTM): $34.44 M
Dividend Yield: 3.4137437718909%
ROE: 95.59%
Latest News
-
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Fri, May 8, 2026 1:25 PM
-
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Fri, May 8, 2026 12:02 PM
-
AbbVie (ABBV), adMare BioInnovations Name RIME Therapeutics as Biotech Innovators Award Winner
Fri, May 8, 2026 11:17 AM
-
Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain
Thu, May 7, 2026 9:24 PM
-
AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines.
Thu, May 7, 2026 6:55 PM
-
Does Strong Q1 Results And SKYRIZI Expansion Reshape The Bull Case For AbbVie (ABBV)?
Thu, May 7, 2026 6:25 AM
-
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?
Wed, May 6, 2026 8:20 PM
-
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash
Wed, May 6, 2026 2:32 PM
-
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
Wed, May 6, 2026 2:04 PM
-
DDW 2026: key readouts from the conference
Wed, May 6, 2026 12:26 PM
Key Financials
Financial data not available